MacKinnon and colleagues conducted a meta-analysis of 21 randomized, controlled trials of an ACE inhibitor plus an ARB in patients with chronic diabetic or nondiabetic (e.g. IgA nephropathy or ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback